Department of Neurology, Children's Hospital Capital Institute of Pediatrics, Beijing, 100020, People's Republic of China.
Graduate School of Peking Union Medical College, Beijing, 100730, People's Republic of China.
BMC Musculoskelet Disord. 2021 Aug 24;22(1):729. doi: 10.1186/s12891-021-04613-x.
Patients with spinal muscular atrophy (SMA) are at risk of decreased bone mineral density (BMD). The bone health status of Chinese patients with SMA has been poorly studied. We aimed to evaluate the BMD of children with SMA types 2 and 3 in mainland China and investigate its influencing factors.
Forty patients with a mean age of 5.5 years affected by SMA types 2 and 3 (n = 22 and n = 18, respectively) were enrolled between September 2017 and May 2019. Total body less head (TBLH) BMD, lumbar spine (LS) BMD, and body composition were measured using dual-energy X-ray absorptiometry (DXA). Serum bone metabolism markers and complete spinal radiographs were assessed. We utilized a linear regression model to explore the correlations between BMD and its related factors.
A total of 67.5% (27/40) of patients were diagnosed with low BMD and 2.5% (1/40) were diagnosed with osteoporosis. The TBLH BMD and LS BMD Z-scores in children with SMA type 2 were significantly lower than those with SMA type 3. Both TBLH and LS BMD Z-scores tended to increase with the change of SMA subtypes from 2a-3b. Vitamin D insufficiency and deficiency were found in 37.5% (15/40) of the patients. Serum Ca, phosphorus (P), alkaline phosphatase (ALP) and parathormone (PTH) levels were normal. There were no significant differences among the four subtypes in terms of all the serum bone metabolism markers. Phenotype was significantly associated with TBLH BMD and LS BMD Z-scores, and serum PTH levels were significantly associated with TBLH BMD Z-scores.
Low BMD and osteoporosis were highly prevalent in mainland Chinese children with SMA types 2 and 3. Phenotype and serum PTH level might be the influencing factors of BMD. Regular monitoring of BMD by DXA scan and taking active interventions aim to SMA children with different types are important.
脊髓性肌萎缩症(SMA)患者存在骨密度(BMD)降低的风险。中国 SMA 患者的骨骼健康状况尚未得到充分研究。本研究旨在评估中国大陆 2 型和 3 型 SMA 患儿的 BMD,并探讨其影响因素。
2017 年 9 月至 2019 年 5 月,共纳入 40 例 SMA 2 型和 3 型患儿(22 例和 18 例,分别为 n=22 和 n=18)。采用双能 X 线吸收法(DXA)测量全身(不包括头部)BMD、腰椎(LS)BMD 和身体成分。检测血清骨代谢标志物和全脊柱 X 线片。我们利用线性回归模型探讨 BMD 与相关因素之间的关系。
40 例患儿中,67.5%(27/40)被诊断为低 BMD,2.5%(1/40)被诊断为骨质疏松症。SMA 2 型患儿的全身(不包括头部)BMD 和 LS BMD Z 评分明显低于 SMA 3 型患儿。随着 SMA 亚型从 2a-3b 的变化,全身(不包括头部)和 LS BMD Z 评分均有升高的趋势。37.5%(15/40)的患儿存在维生素 D 不足或缺乏。血清 Ca、P、碱性磷酸酶(ALP)和甲状旁腺激素(PTH)水平正常。四种亚型患儿的血清骨代谢标志物无明显差异。表型与全身(不包括头部)和 LS BMD Z 评分显著相关,血清 PTH 水平与全身(不包括头部)BMD Z 评分显著相关。
中国大陆 2 型和 3 型 SMA 患儿普遍存在低 BMD 和骨质疏松症。表型和血清 PTH 水平可能是 BMD 的影响因素。对不同类型 SMA 患儿进行 DXA 扫描监测 BMD,并采取积极干预措施非常重要。